#LCSM is an active hashtag on Bluesky. In the last 30 days, 11 people shared 74 posts with it — around 2 a day. Activity is up 0% versus the previous week, peaking on Oct 14 with 12 posts.

Posts with #LCSM

Lung Cancer Europe

@lungcancereurope.bsky.social

3 days ago

Climate change could be raising #lungcancer risk inside our homes. 🌡️ As rising temps drive us into sealed, air-conditioned rooms & basements, radon builds up. Modelling from a 🆕 study suggests up to 42 extra deaths per 10,000 people in Europe by age 85. www.nature.com/articles/s44... #LCSM

0 2 10

Lung Cancer Europe

@lungcancereurope.bsky.social

about 13 hours ago

The cost of #lungcancer goes far beyond health. 💶 At #ESMO26, our President Debra Montague presented our poster showing 2 in 3 people affected by lung cancer face financial difficulties, & 82% of those struggling say money is a barrier to treatment & care. 📍 Poster 3975P shorturl.at/ahecY #LCSM

0 0 4

ALK Positive Lung Cancer UK

@alkpositiveuk.bsky.social

1 day ago

TRIANA is on the programme at #ESMO2026 🔬 This Phase 1/2 trial in ALK+ #lungcancer tests TRI-611, a molecular glue designed to break down the ALK protein rather than block it. Still early research, with no results yet. More at www.alkpositive.org.uk/in…. Poster 2872 eTIP #LCSM

0 0 4

All You Need is Lungs

@allyouneedislungs.bsky.social

3 days ago

Could hotter summers increase #lungcancer deaths? New research warns that changes to how we cool our homes could increase exposure to radon, a radioactive gas that causes lung cancer, including in people who have never smoked. The risk is invisible. doi.org/10.1038/s444... #LCSM

0 4 8

Lung Cancer Europe

@lungcancereurope.bsky.social

1 day ago

Leaked before #ESMO26: a personalised mRNA vaccine plus pembrolizumab lowered the risk of melanoma returning, or death, by 42%. The same vaccine is in Phase 3 trials for early-stage #lungcancer, made from each person's tumour after surgery. Lung results are still to come. shorturl.at/ND9zg #LCSM

0 0 4

Lung Cancer Europe

@lungcancereurope.bsky.social

2 days ago

Lung Cancer Europe is in Madrid for #ESMO26. 🇪🇸 It's a big year for #lungcancer, with new trial results that could change treatment. On Saturday, our President presents our research on the cost of lung cancer: 2 in 3 people we surveyed were struggling financially. 📍 3975P, Sat 24 Oct, 12:00 #LCSM

0 0 4

Lung Cancer Europe

@lungcancereurope.bsky.social

4 days ago

No agreed treatment once small cell #lungcancer comes back. From RESONANCE, to be presented at #ESMO26: 623 people with ext-stage SCLC in France, Germany, Italy, Spain and the UK. Authors point to a likely reason: too few effective options. If this Western Europe. What about the rest? #LCSM

0 0 5

OncLive

@onclive.bsky.social

about 4 hours ago

A standing ovation: Tarlatamab + durvalumab as frontline maintenance in ES-SCLC, phase 3 DeLLphi-305. Data presented at the @myesmo.bsky.social #ESMO26 Presidential Symposium support a new SOC. #lcsm #medtwitter #oncology @danafarber.bsky.social www.onclive.com/view/dell….

www.onclive.com

DeLLphi-305 Data Support Frontline Maintenance Tarlatamab Plus Durvalumab as a New SOC in ES-SCLC | OncLive

Adding tarlatamab-dlle to durvalumab maintenance extended survival in extensive-stage small cell lung cancer in the phase 3 DeLLphi-305 trial.

0 0 1

Lung Cancer Europe

@lungcancereurope.bsky.social

about 9 hours ago

Big ESMO 2026 news for extensive-stage small cell #lungcancer: phase III DeLLphi-305 shows tarlatamab + durvalumab extended median survival to 21.1 vs 12.7 months on durvalumab alone. 58% lower risk of death. Both drugs already exist in Europe. Access is the next fight. #LCSM

1 0 1

OncLive

@onclive.bsky.social

1 day ago

Poll Results: Readers share their opinions on some of the most talked-about lung cancer abstracts they’re looking forward to seeing at #ESMO2026. @myesmo.bsky.social #lcsm #oncology Full recap ➡️: www.onclive.com/view/poll….

www.onclive.com

Polls Reveal Top Picks for Lung Cancer Abstracts of Interest at ESMO 2026 | OncLive

Readers share their opinions on some of the most talked-about lung cancer abstracts they’re looking forward to seeing at ESMO 2026.

0 0 1

ALK Positive Lung Cancer UK

@alkpositiveuk.bsky.social

5 days ago

Many people with ALK-positive #lungcancer are diagnosed during busy, active years of life: working, raising children, caring for family. 72% were working at diagnosis. Of those, 51% stopped working because of their lung cancer. 2026 Demographics Report: tr.ee/jAki-M0aYK #LCSM

0 0 5

All You Need is Lungs

@allyouneedislungs.bsky.social

5 days ago

Air pollution is a known cause of #lungcancer, including in people who have never smoked. Now 150 scientists, MPs and campaigners are calling for a UK inquiry into why some communities face higher pollution levels than others. www.allyouneedislungs.org…. #LCSM